Showing 2441-2450 of 3134 results for "".
- Sadick and Sadick Featured at Cutera Beauty Talkhttps://modernaesthetics.com/news/sadick-and-sadick-featured-at-cutera-beauty-talk/2471934/Dermatologist Neil Sadick MD and his daughter Sydney Sadick, an in the know fashion journalist, talked about everything from state-of-the-art skin brightening treatments to the newest injectables and how to get svelte without sweating or surgery at
- ASPS 2018 Data: Plastic Surgery is on the Rise and It's All About the Bodyhttps://modernaesthetics.com/news/asps-2018-data-plastic-surgery-is-on-the-rise-and-its-all-about-the-body/2471942/It’s official. Plastic surgery is on the rise. There were nearly 18 million more cosmetic procedures performed in 2018 than 2017, and this number has risen steadily over the past five years, according to the 2018 statistics from the
- Cutera Launches excel V+ the Next Generation Laser Platformhttps://modernaesthetics.com/news/cutera-launches-excel-v-the-next-generation-laser-platform/2471949/Cutera, Inc. has launched its excel V+ laser platform, which the company describes as a technological advancement that includes 50 percent more power and treatment speed, optimized delivery systems and parameters for treating vascular lesions and pigmentation concerns. The company says th
- Evolus: Jeuveau FDA Cleared for Aesthetic Injectionhttps://modernaesthetics.com/news/evolus-jeuveau-fda-cleared-for-aesthetic-injection/2471954/The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. It will be available to physicians this sp
- Galderma Announces Formation of Women in Aesthetics Leadership Councilhttps://modernaesthetics.com/news/galderma-announces-formation-of-women-in-aesthetics-leadership-council/2471960/Galderma Laboratories, L.P. is forming a Women in Aesthetics Leadership Council. The newly formed Council is comprised of clinicians, clinical trial investigators, CEOs, business owners, and practice managers. "In most industries in the U.S. wome
- RealSelf: One-Third of US Adults Are Considering Cosmetic Treatmentshttps://modernaesthetics.com/news/realself-one-third-of-us-adults-are-considering-cosmetic-treatments/2471963/More than four in five U.S. adults want to improve their personal well-being or appearance in 2019, and 36 percent are considering cosmetic treatments, according to new RealSelf survey. Fully 82 percent of U.S. adults plan to make changes related to their personal well-being and/or appear
- Leadership Change at Cutera; Preliminary Financial Results for 2018https://modernaesthetics.com/news/leadership-change-at-cutera-preliminary-financial-results-for-2018/2471966/Cutera has announced the resignation of James Reinstein as President, Chief Executive Officer and member of its Board of Directors, effective immediately. The Board has appointed Cutera’s Chief Operating Officer, Jason Richey, as Interim CEO. J. Daniel Plants, Chairman of Cutera, sa
- Suneva to Add Two New Products to Aesthetics Portfoliohttps://modernaesthetics.com/news/suneva-to-add-two-new-products-to-aesthetics-portfolio/2471967/Suneva® Medical, Inc., is partnering with
- ASAPS Releases 2019 Plastic Surgery Predictionshttps://modernaesthetics.com/news/asaps-releases-2019-plastic-surgery-predictions/2471968/The coming year will herald less emphasis on celebrity emulation and more emphasis on a tailored, individual look, according to 2019 predictions from
- Revance Shares Positive Efficacy and Duration Data for RT002https://modernaesthetics.com/news/revance-share-positive-efficacy-and-duration-data-for-rt002/2471986/Revance Therapeutics, Inc.'s long-acting neuromodulator daxibotulinumtoxinA for Injection (RT002) with its proprietary stabilizing excipient peptide technology delivered positive top-line results in alleviating moderate to severe glabellar lines in the SAKURA 3 Phase 3 open-label, long-term s